Diversified Holdings · Industrial Conglomerates
| Year | Revenue | Net profit | EPS |
|---|---|---|---|
| 2026 | Rs 127.4B | Rs 9.3B | 2.98 |
| 2025 | Rs 118.0B | Rs 8.3B | 2.70 |
| 2024 | Rs 121.6B | Rs 6.4B | 10.24 |
| 2023 | Rs 113.9B | Rs 5.1B | 7.16 |
| 2022 | Rs 78.8B | Rs 4.8B | 7.12 |
| 2021 | Rs 64.5B | Rs 3.3B | 5.46 |
| 2020 | Rs 61.6B | Rs 1.4B | 2.07 |
Hemas Holdings PLC is a diversified Sri Lankan conglomerate with principal activities across consumer goods, healthcare, mobility, leisure, travel and aviation, and logistics and maritime services. The Group markets home and personal care and other consumer products domestically and in regional markets, and has a portfolio of businesses across pharmaceuticals, hospitals, hospitality and travel. The Healthcare vertical comprises pharmaceutical distribution and manufacturing (Morison), and a hospitals group operating facilities such as Wattala and Thalawathugoda; the Consumer vertical includes home and personal care categories and brands such as Atlas (including a 'Back to School' range). The Group also operates hotels and inbound travel businesses including Serendib Hotels (SHOT) and Anantara Peace Haven Tangalle, and maintains operations in Sri Lanka with regional presence in Bangladesh, West Bengal and Myanmar. Hemas positions itself as a national leader in consumer and healthcare solutions, seeking to develop brands, commercial partnerships and manufacturing capacity while engaging in route-to-market and regulatory initiatives relevant to its sectors.
No AI research report for Hemas Holdings Ltd. yet. Generate one from everything we track: prices, valuation, news sentiment, financials and corporate actions.
Generate an analysis →1 article in 30 days: 0 positive, 1 negative, 0 neutral.
Hemas Holdings PLC appointed Sabrina Esufally as an Executive Director, effective 1 July 2026. She is Managing Director of Hemas Consumer Brands and brings commercial and consumer leadership to the Group Board.
Hemas Holdings appointed Sabrina Esufally as an Executive Director effective 1 July 2026. She is Managing Director of Hemas Consumer Brands, has led the group's consumer and pharmaceutical initiatives since 2019, and will add commercial and consumer leadership to the board.
Hemas Holdings reported a 17.6% rise in profit to Rs 3.03 billion for the March 2026 quarter. Consolidated revenue rose 3.9% to Rs 31.54 billion, with healthcare the largest contributor and a final dividend of Rs 0.75 per share approved.
Hemas Holdings (HHL) reported record earnings: Group earnings of Rs.3.03Bn in Q4 (+17.6% YoY) and Rs.8.92Bn for FY26 (+10.7% YoY) on FY26 revenue of Rs.127.4Bn (+8.0%). The group is reinvesting into digital, manpower and healthcare expansion, compressing EBITDA/EBIT margins but delivering higher net profit margin and EPS.
Hemas Holdings (HHL) reported record FY2025/26 results with group earnings of Rs.8.92 bn (up 10.7% YoY) and revenue of Rs.127.4 bn (up 8%). The group has earmarked over $100m for investments over the next four years and expects an FY27 acquisition to raise international revenue to 10% from 3%.
Hemas Holdings will issue up to 33.5 million shares (1.12% of issued) under a proposed Employee Share Option Scheme. Current stated capital is Rs.7.99bn (2.99bn shares); total ESOS/ESOP issuance capped at 5% and the plan requires exchange and shareholder approval.
Dividend · Rs 0.75 · XD Jun 30, 2026
Final dividend of LKR 0.75/share; XD 2026-06-30; record 2026-06-30; payable 2026-07-17; FY ended 31.03.2026
EPF fully exited holdings in six CSE-listed companies in 2025 — Cargills Bank, Ceylon Hotels, Colombo Dockyard, Jetwing Symphony, LAUGFS Gas and Sierra Cables — and made one new investment, buying 40 million shares in Hemas Holdings; its listed equity count fell from 65 to 59.
Hayleys PLC’s proposed unsecured senior redeemable debentures of up to LKR7 billion were assigned a 'AAA(lka)' National Long-Term Rating by Fitch. Fitch noted subsidiary debt to consolidated EBITDA rose to 2.9x in 3QFY26, expects it to moderate to ~2.5x by FY27 and said failure could lower the debentures one notch.
Fitch assigned a 'AAA(lka)' National Long-Term Rating to Hayleys PLC's proposed unsecured senior redeemable debentures of up to LKR7 billion. Fitch noted subsidiary debt-to-consolidated-EBITDA rose to 2.9x in 3QFY26 (limit 2.5x) but expects it to moderate toward 2.5x in FY27, otherwise ratings risk.